Tussionex Pennkinetic Extended-Release Suspension

Chlorpheniramine/Hydrocodone Extended-Release Suspension

On March 11, 2008, the Food and Drug Administration (FDA) issued a public health advisory concerning the safety of UCB’s Tussionex Pennkinetic Extended-Release Suspension, a prescription cough medicine containing hydrocodone and the antihistamine chlorpheniramine.